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ABSTRACT 
 
Background and Aims: Middle ear surgeries require bloodless field for better 
visibility of the surgical field under operating microscope. Dexmedetomidine, 
an alpha 2 agonist could provide desired surgical field, sedation and analgesia 
as suggested by recent studies. Our study was aimed to evaluate the clinical 
effects of dexmedetomidine infusion during middle ear surgeries under general 
anaesthesia to provide bloodless field and its effect on requirement of volatile 
agents.  
Methods: sixty adult patients aged 18-45years, American society of 
Anaesthesiologists Grades I and II, of both gender were randomized into two 
comparable equal groups of 30 patients each using standard technique for 
middle ear surgery under general anaesthesia. After induction patients of Group 
I were given dexmedetomidine infusion of 0.5µg/kg/hour and patients of Group 
II were given placebo infusion of normal saline till 20 minutes before end of the 
surgery. Sevoflurane concentration was titrated to reach target blood pressure of 
less than 30% of baseline systolic blood pressure or less than 30% of base line 
mean arterial pressure whichever was higher. At the end of the procedure 
surgeon was asked to assess bleeding in a graded scale. 
Results: Statistically significant reduction in mean heart rate was observed 
throughout the procedure (p <0.0001) in dexmedetomidine group than normal 
saline. Patients receiving dexmedetomidine showed statistically significant 
reduction in the requirement of sevoflurane to achieve and maintain target blood 
pressure (0.72±0.13) when compared to those receiving placebo infusions 
(1.43±0.32). The time taken to reach target blood pressure was significantly less 
in dexmedetomidine group (24±7.24mins) when compared to those receiving 
placebo infusion(48.67±8.60mins). Patients receiving dexmedetomidine had 
statistically significant lesser surgical site bleeding when compared to patients 
receiving placebo infusion (p<0.0001). 
Conclusion: Dexmedetomidine infusion can be given as adjunct to general 
anaesthesia in middle ear surgeries to provide blood less surgical field, to 
reduce the requirement of sevoflurane and faster onset of controlled 
hypotension. 
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